10-QPeriod: Q2 FY2003

CENTENE CORP Quarterly Report for Q2 Ended Jun 30, 2003

Filed July 28, 2003For Securities:CNC

Summary

Centene Corporation's (CNC) 10-Q filing for the period ending June 30, 2003, indicates robust revenue growth driven by significant membership increases across its Medicaid and SCHIP programs. The company experienced a substantial rise in premium revenues, largely attributed to organic growth in existing markets, strategic acquisitions like the purchase of GPA and ScriptAssist assets, and the integration of new members from acquisitions such as Superior HealthPlan and University Health Plans. This expansion is a key indicator of Centene's ability to scale its operations and capture a larger share of the managed care market. While profitability saw an increase, investors should note the slight rise in the health benefits ratio, particularly due to the inclusion of SSI members in New Jersey. However, management expects this ratio to normalize as these members integrate into existing programs. The company's strategic focus on diversifying into specialty services and expanding its geographic reach is evident, with ongoing efforts to acquire new contracts and potentially enter new states. Centene also continues to invest in technology and infrastructure to support its growth and meet regulatory requirements, signaling a commitment to long-term operational efficiency and compliance.

Key Highlights

  • 1Total revenues increased significantly to $363.7 million for the six months ended June 30, 2003, up from $203.4 million in the prior year period, primarily driven by premium revenue growth.
  • 2Membership grew by 57% year-over-year, reaching 438,700 members as of June 30, 2003, across Wisconsin, Texas, Indiana, and New Jersey.
  • 3Net earnings increased to $14.9 million for the six months ended June 30, 2003, compared to $9.5 million in the same period last year, reflecting strong revenue performance.
  • 4The company made strategic acquisitions, including a 63.7% interest in Group Practice Affiliates (GPA) and the purchase of ScriptAssist contract rights, to diversify into specialty services.
  • 5Cash flows from operations provided $9.4 million for the first six months of 2003, a slight increase from $8.9 million in the prior year, indicating stable operational cash generation.
  • 6Centene is actively pursuing future growth through a proposed public offering of common stock, with proceeds intended for working capital and potential acquisitions.
  • 7The company's health benefits ratio for the core Medicaid business remained stable, though it saw an increase due to the inclusion of SSI members in New Jersey, which management expects to improve.

Frequently Asked Questions

Centene's revenue growth was primarily driven by a substantial increase in premium revenues, which rose by 76.8% to $359.1 million for the six months ended June 30, 2003. This increase was fueled by organic membership growth in existing markets, the strategic acquisition of new members through acquisitions like Superior HealthPlan and University Health Plans, and the successful integration of new contracts, such as the Texas SCHIP contracts.

Centene manages its expenses through various strategies, including negotiating contracts with healthcare providers and emphasizing preventive care. The company closely monitors its health benefits ratio, which represents medical costs as a percentage of premium revenues. While the ratio increased slightly due to the inclusion of SSI members in New Jersey, management expects it to improve as these members are integrated. The company also focuses on managing general and administrative expenses, which increased to support membership growth but remained relatively stable as a percentage of total revenues.

Centene's growth strategy involves continued membership expansion through organic growth and acquisitions. The company is actively diversifying its business lines into specialty services, such as behavioral health and medication compliance, through strategic investments like GPA and ScriptAssist. Furthermore, Centene is planning a public offering of its common stock to raise capital for working capital and potential future acquisitions, including expanding into new states and acquiring more Medicaid and SCHIP contracts.

Key risks highlighted include significant reliance on government funding (Medicaid and SCHIP), potential for contract termination or non-renewal, changes in government regulations that could impact operations and profitability, intense competition, and the need to effectively manage medical costs and accurately predict medical expenses. The company also faces risks related to integrating acquired businesses and maintaining strong relationships with its provider networks.